Medications for Nonmetastatic Castrationsensitive Prostate Carcinoma

1 result
  • xtandi - enzalutamide capsule

    (Enzalutamide)
    Astellas Pharma Us, Inc.
    Xtandi treats castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer (mCSPC), and non-metastatic castration-sensitive prostate cancer (nmCSPC) with high-risk biochemical recurrence.